Building artificial intelligence to study the sun

Building artificial intelligence to study the sun

Dec. 15, 2020

Dr. Thomas Berger, the executive director of CU Boulder's Space Weather Technology, Research and Education Center, is leading a team that has received a two-year, $496K grant to design a better forecasting system for solar magnetic eruptions on the sun, using machine learning.

CU Boulder physicists honored by National Academy of Inventors

CU Boulder physicists honored by National Academy of Inventors

Dec. 14, 2020

Margaret Murnane and Henry Kapteyn, physics professors and JILA Fellows at CU Boulder, have been named fellows of the National Academy of Inventors. Murnane and Kapteyn pioneered technologies for generating coherent X-rays, which helped propel research in dynamic processes in atoms, molecules and materials.

OSTP quantum division highlights Q-SEnSE leadership in quantum sensing

OSTP quantum division highlights Q-SEnSE leadership in quantum sensing

Dec. 9, 2020

Led by CU Boulder and designed to push the frontiers of quantum sensing, Quantum Systems through Entangled Science and Engineering (Q-SEnSE) involves 37 researchers from 12 organizations located in 6 different states (including one collaborating from Europe).

New DEPA reporting system for conflicts of interest disclosures

New DEPA reporting system for conflicts of interest disclosures

Dec. 7, 2020

The Office of Conflicts of Interest & Commitment (COIC) is transitioning to a new InfoEd reporting system, which includes a revamp of the disclosure form (DEPA Form). The transition to the InfoEd reporting system and the new DEPA Form is underway and will be in effect for 2021.

Infectious disease containment, anxiety disorder interventions among collaborative projects funded by AB Nexus grants

Infectious disease containment, anxiety disorder interventions among collaborative projects funded by AB Nexus grants

Dec. 3, 2020

The AB Nexus Research Collaboration Grant program announced its inaugural round of grants totaling $625K for novel research projects integrating expertise from the CU Anschutz and Boulder campuses. The projects involve a broad range of research themes related to basic science and translational approaches.

COVID-19 update for the CU Boulder research community

COVID-19 update for the CU Boulder research community

Nov. 20, 2020

We continue to ask employees and researchers who are not already approved for on-campus or field work to continue remote work until instructed otherwise. Anyone performing work that has been approved should follow all CU Boulder, Boulder County and Colorado guidance.

Innovative partnership with Kiewit prepares infrastructure engineers

Innovative partnership with Kiewit prepares infrastructure engineers

Nov. 17, 2020

CU Boulder has partnered with Kiewit, one of the nation’s largest construction and engineering organizations, to launch the Kiewit Design-Build Program, designed to meet the nation's infrastructure challenges for years to come. Through the program, Kiewit makes a five-year commitment to support up to 40 students each year.

Tiny moon shadows may harbor hidden stores of ice

Tiny moon shadows may harbor hidden stores of ice

Nov. 17, 2020

Hidden pockets of water could be much more common on the surface of the moon than scientists once suspected, according to new research led by CU Boulder. In some cases, these tiny patches of ice might exist in shadows no bigger than a penny that have gone without a single ray of sunlight for billions of years.

Lab Venture Challenge showcase for innovations with high commercial potential (Nov 18 & 19)

14 researchers to pitch their innovations for funding at Lab Venture Challenge (Nov. 18 & 19)

Nov. 17, 2020

Through the Lab Venture Challenge, Venture Partners at CU Boulder funds the university's top innovations addressing a commercial need, with a clear path to a compelling market and strong scientific support. This showcase is a can't-miss event to see breakthrough innovations.

Bristol Myers Squibb acquires MyoKardia, co-founded by CU Boulder faculty, for $13.1 billion in cash

Bristol Myers Squibb acquires MyoKardia, co-founded by CU Boulder faculty, for $13.1 billion in cash

Nov. 17, 2020

MyoKardia, a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases, was co-founded by Leslie Leinwand, Distinguished Professor of Molecular, Cellular, and Developmental Biology at CU Boulder's BioFrontiers Institute.

Pages